{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:01:05Z","timestamp":1784959265600,"version":"3.55.0"},"reference-count":21,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.26-0308","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:12:16Z","timestamp":1784931136000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["A Shared Genomic Alteration Supported the Diagnosis of Two Tumors in the Remnant Pancreas 7 Years after Resection of Distal Cholangiocarcinoma"],"prefix":"10.70352","volume":"12","author":[{"given":"Hanako","family":"Tamura","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kinowaki","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Pathology, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shintaku","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Furuyama","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Katsuta","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Akahoshi","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadakatsu","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ban","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol 2009; 10: 287\u201393.","DOI":"10.1016\/S1470-2045(09)70065-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hooper JE, Morgan TK, Grompe M, et al. The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma. Hum Pathol 2012; 43: 1583\u20139.","DOI":"10.1016\/j.humpath.2011.11.012"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Takenami T, Maeda S, Karasawa H, et al. Novel biomarkers distinguishing pancreatic head cancer from distal cholangiocarcinoma based on proteomic analysis. BMC Cancer 2019; 19: 318.","DOI":"10.1186\/s12885-019-5548-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Matsubara A, Nara S, Sekine S, et al. Intraductal dissemination of papillary adenocarcinoma of the ampulla of Vater in the pancreatic duct. Pathol Int 2014; 64: 39\u201344.","DOI":"10.1111\/pin.12131"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Higashi Y, Shimizu K, Watanabe T, et al. Intraductal dissemination of bile duct carcinoma with pancreaticobiliary maljunction in the pancreatic duct after pancreatoduodenectomy. Jpn J Gastroenterol Surg 2017; 50: 393\u2013400. (in Japanese)","DOI":"10.5833\/jjgs.2016.0110"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kosuge S, Noji T, Go M, et al. A case of solitary pancreatic metastasis from gallbladder cancer. Jpn J Gastroenterol Surg 2023; 56: 487\u201395. (in Japanese)","DOI":"10.5833\/jjgs.2022.0097"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Zehir A, Benayed R, Shah RH, et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 2017; 23: 703\u201313.","DOI":"10.1038\/nm.4333"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ota Y, Matsuyama R, Taniguchi K, et al. Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a case. Clin J Gastroenterol 2013; 6: 485\u20139.","DOI":"10.1007\/s12328-013-0432-8"},{"key":"9","unstructured":"9) National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: biliary tract cancers. Version 1.2026. March 10, 2026."},{"key":"10","unstructured":"10) National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: pancreatic adenocarcinoma. Version 1.2026. March 18, 2026."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273\u201381.","DOI":"10.1056\/NEJMoa0908721"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid 2022; 1: EVIDoa2200015.","DOI":"10.1056\/EVIDoa2200015"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023; 401: 1853\u201365.","DOI":"10.1016\/S0140-6736(23)00727-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Lamarca A, Palmer DH, Wasan HS, et al. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Lancet Oncol 2021; 22: 690\u2013701.","DOI":"10.1016\/S1470-2045(21)00027-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691\u2013703.","DOI":"10.1056\/NEJMoa1304369"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Wang-Gillam A, Li CP, Bodoky G, et al. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet 2016; 387: 545\u201357.","DOI":"10.1016\/S0140-6736(15)00986-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Neuzillet C, Hentic O, Rousseau B, et al. FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts. World J Gastroenterol 2012; 18: 4533\u201341.","DOI":"10.3748\/wjg.v18.i33.4533"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Golan T, Hammel P, Reni M, et al. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med 2019; 381: 317\u201327.","DOI":"10.1056\/NEJMoa1903387"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Abou-Alfa GK, Sahai V, Hollebecque A, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol 2020; 21: 671\u201384.","DOI":"10.1016\/S1470-2045(20)30109-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Loriot Y, Necchi A, Park SH, et al. Erdafitinib in locally advanced or metastatic urothelial carcinoma. N Engl J Med 2019; 381: 338\u201348.","DOI":"10.1056\/NEJMoa1817323"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Krook MA, Reeser JW, Ernst G, et al. Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance. Br J Cancer 2021; 124: 880\u201392.","DOI":"10.1038\/s41416-020-01157-0"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0308\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:25:19Z","timestamp":1784957119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0308\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.26-0308","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.26-0308"}}